| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/15/2000 | US6024962 Mercaptan gene and amine terminus with amine acid nucleic acid sequence |
| 02/15/2000 | US6024961 Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
| 02/15/2000 | US6024958 Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | US6024956 Interleukins and antiinflammatrory agents |
| 02/15/2000 | US6024955 Peptide with amino acid sequences |
| 02/15/2000 | US6024954 Compositions and methods for disinfecting contact lenses and preserving contact lens care products |
| 02/15/2000 | US6024953 Prevention of rabies in mammals, administering a hybrid vaccine |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | CA2093667C Mouse monoclonal antibodies and uses thereof |
| 02/15/2000 | CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| 02/15/2000 | CA2004478C Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| 02/15/2000 | CA1340899C Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques |
| 02/15/2000 | CA1340896C Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins |
| 02/14/2000 | CA2280061A1 Method of prevention and treatment of multiple sclerosis with varicella zoster immune globulin |
| 02/12/2000 | CA2248989A1 Novel compounds |
| 02/10/2000 | WO2000006764A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | WO2000006745A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/10/2000 | WO2000006744A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006741A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006738A2 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/10/2000 | WO2000006737A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 02/10/2000 | WO2000006736A2 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | WO2000006733A2 T cell receptor proteins, nucleic acid molecules, and uses thereof |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006729A1 Kdel receptor inhibitors |
| 02/10/2000 | WO2000006723A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 02/10/2000 | WO2000006716A1 Growth differentiation factor-11 |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy |
| 02/10/2000 | WO2000006604A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 02/10/2000 | WO2000006602A1 Cancer antigens based on tumor suppressor gene wt1 product |
| 02/10/2000 | WO2000006599A1 Inhibitors of hiv membrane fusion |
| 02/10/2000 | WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 02/10/2000 | WO2000006534A1 Compounds and compositions for delivering active agents |
| 02/10/2000 | WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | WO2000006203A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 02/10/2000 | WO2000006198A2 Adjuvant comprising pulmonary surfactant |
| 02/10/2000 | WO2000006197A1 Combined vaccine for immunoprophylaxis against viral hepatitis b and d, tetanus and diphtheria |
| 02/10/2000 | WO2000006196A2 Multivalent human-bovine rotavirus vaccine |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006190A1 THYMOSIN β4 PROMOTES WOUND REPAIR |
| 02/10/2000 | WO2000006184A1 Pulmonary delivery of active agents |
| 02/10/2000 | WO2000006181A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 02/10/2000 | WO2000006178A1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 02/10/2000 | WO2000006123A1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 02/10/2000 | WO2000006032A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | WO2000000825A3 Detection and modulation of cellular immunity to immune privileged antigens |
| 02/10/2000 | WO1999064603A3 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
| 02/10/2000 | WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 02/10/2000 | WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 02/10/2000 | WO1999060024A9 Methods for amyloid removal using anti-amyloid antibodies |
| 02/10/2000 | WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/10/2000 | WO1999058557A3 Dimers of the hla-b27 heavy chain extracellular domain and uses thereof |
| 02/10/2000 | WO1999058139A3 Methods for detecting and inhibiting angiogenesis |
| 02/10/2000 | WO1999054479A9 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES |
| 02/10/2000 | WO1999049045A3 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 02/10/2000 | WO1999049039A3 GFRα3 AND ITS USES |
| 02/10/2000 | WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/10/2000 | WO1999036105A3 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
| 02/10/2000 | CA2340855A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | CA2338928A1 Thymosin .beta.4 promotes wound repair |
| 02/10/2000 | CA2338870A1 Adjuvant comprising pulmonary surfactant |
| 02/10/2000 | CA2338773A1 Ex vivo treatment of allogeneic and xenogeneic t-cells with gp39 antagonists |
| 02/10/2000 | CA2338396A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2338022A1 Inhibitors of hiv membrane fusion |
| 02/10/2000 | CA2338001A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | CA2337743A1 Tumor antigen based on products of the tumor suppressor gene wt1 |
| 02/10/2000 | CA2337692A1 Kdel receptor inhibitors |
| 02/10/2000 | CA2337493A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2337102A1 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | CA2337092A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336875A1 Multivalent human-bovine rotavirus vaccine |
| 02/10/2000 | CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336536A1 Growth differentiation factor-11 |
| 02/10/2000 | CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2304596A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 02/09/2000 | EP0978559A2 Induction of tumour immunity by redirection of tumour cells against antigen presenting cells |
| 02/09/2000 | EP0978287A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 02/09/2000 | EP0978286A1 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 02/09/2000 | EP0977893A1 Reagents and methods useful for detecting diseases of the prostate |
| 02/09/2000 | EP0977879A2 Eukaryotic gene expression cassette and uses thereof |
| 02/09/2000 | EP0977874A1 Attenuated salmonella strain used as a vehicle for oral immunization |
| 02/09/2000 | EP0977872A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/09/2000 | EP0977864A2 Antigenic composition and method of detection for helicobacter pylori |
| 02/09/2000 | EP0977856A1 Lag-3 splice variants |
| 02/09/2000 | EP0977855A2 Polypeptides associated with activator receptors and their biological applications |
| 02/09/2000 | EP0977852A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/09/2000 | EP0977845A1 Human sodium-dependent phosphate cotransporter |
| 02/09/2000 | EP0977844A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof |
| 02/09/2000 | EP0977843A1 Novel human transmembrane 4 superfamily protein |
| 02/09/2000 | EP0977834A2 Human serine protease precursor |
| 02/09/2000 | EP0977832A1 Method for inactivating a virus |